首页> 美国卫生研究院文献>Journal of Clinical Microbiology >Molecular Identification and Antifungal Susceptibility Testing of Clinical Isolates of the Candida rugosa Species Complex and Proposal of the New Species Candida neorugosa
【2h】

Molecular Identification and Antifungal Susceptibility Testing of Clinical Isolates of the Candida rugosa Species Complex and Proposal of the New Species Candida neorugosa

机译:皱念珠菌种群临床分离株的分子鉴定和抗真菌药敏试验及新种念珠菌的提议

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Candida rugosa is a poorly known fungal species occasionally involved in human infections. A molecular analysis of the sequences of the D1/D2 domains and the internal transcribed spacer (ITS) region of the ribosomal genes of 24 clinical isolates phenotypically identified as C. rugosa demonstrated that only 10 (41.6%) isolates belonged to that species. The other isolates were identified as Candida pararugosa (41.6%) and Candida pseudorugosa (8.3%). The remaining two isolates, from human and equine infections, respectively, were clearly different from the others and represent a new species proposed here as Candida neorugosa. The closest species by D1/D2 sequences was the type strain of C. rugosa, with only 92.3% similarity. C. neorugosa can also be differentiated from all other species of the C. rugosa complex by phenotypic features. The eight antifungal drugs tested showed high in vitro activity against the 24 isolates included in the study.
机译:皱皮念珠菌是一种鲜为人知的真菌物种,偶尔与人类感染有关。对表型鉴定为皱纹隐孢子虫的24个临床分离株的核糖体基因的D1 / D2结构域和内部转录间隔区(ITS)区域进行分子分析,结果表明只有10个(41.6%)分离株属于该物种。其他分离株被鉴定为副假丝酵母(41.6%)和假假丝酵母(8.3%)。其余两个分别来自人和马感染的分离株与其他分离株明显不同,代表了这里提出的新假丝酵母菌。 D1 / D2序列最接近的物种是皱纹念珠菌的类型菌株,仅具有92.3%的相似性。还可以通过表型特征将新皱叶隐孢子虫与皱叶隐孢子虫复合物的所有其他物种区分开。测试的八种抗真菌药物对研究中包含的24种分离物表现出很高的体外活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号